Header Logo

Connection

Costica Aloman to Liver Neoplasms

This is a "connection" page, showing publications Costica Aloman has written about Liver Neoplasms.
Connection Strength

0.972
  1. Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatol Commun. 2022 11; 6(11):3247-3259.
    View in: PubMed
    Score: 0.754
  2. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479.e19.
    View in: PubMed
    Score: 0.164
  3. Antibody-directed therapy for human hepatocellular carcinoma. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S225-31.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.